Agilent Technologies has set up a new biopharma experience centre in Hyderabad to support the process of drug development.
“India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation,” Padraig McDonnell, CEO, Agilent Technologies said at the formal inauguration of the Centre here on Tuesday.
“The new centre reflects our commitment to delivering integrated solutions that help bring life-changing therapies to market faster and more efficiently.,’‘ he said.
D. Sridhar Babu, Telangana Minister for IT and Industries, who inaugurated the centre said Hyderabad emerged as a complete healthcare and life sciences ecosystem – from drug discovery and clinical trials to world-class hospitals and affordable, high-quality patient care.
“We are proud to host eight of the top ten global pharma companies, five of India’s leading healthcare chains, and over 230 USFDA-approved manufacturing facilities. Contributing nearly one-third of India’s pharmaceutical production and 40 per cent of bulk drug exports,’‘ he said.
The centre brings together advanced lab technologies, expert training, and regulatory-ready workflows to help researchers, scientists, and companies develop high-quality, life-saving medicines faster and more efficiently.
It offers end-to-end solutions in chromatography, mass spectrometry, cell analysis, and lab informatics, according to the company.
Published on July 29, 2025
